Chemotherapy will frequently induce intestinal damage (mucositis). Enteral nutrition is then often withheld for fear of impaired intestinal absorption as shown in animal models. There is no clinical evidence, however, that absorption is indeed compromised during chemotherapy-induced mucositis. The aim of this study was to evaluate systemic availability of dietary amino acids (leucine) during chemotherapy-induced mucositis. We studied eight childhood cancer patients (age 1.5-16 y) on 2 d, i.e. the day before chemotherapy and 3-5 d after. Chemotherapy-induced oral mucositis and diarrhea were scored on a World Health Organization toxicity scale. Stable isotope tracers were used to measure first-pass splanchnic leucine uptake and whole-body leucine kinetics. Patients showed increased mucositis and/or diarrhea toxicity scores (p Ͻ 0.0001) after chemotherapy. Systemic availability of enterally administered leucine was not significantly affected by chemotherapy (before 60%, after 90%, p ϭ 0.46). Interestingly, five patients already showed a negative leucine balance before chemotherapy. In conclusion, most children receiving chemotherapy are already catabolic before start of a new cycle of chemotherapy. Amino acid transport as measured by leucine uptake in the intestine is not affected by chemotherapyinduced mucositis. C hemotherapy may severely damage the intestinal mucosa, resulting in a condition referred to as mucositis (1,2). Mucositis is characterized by major morphologic changes of the intestinal epithelium, such as epithelial flattening, villus atrophy, and specific down-regulation of the enterocytespecific gene expression that is crucial for degradation and absorption of nutrients (3-5). It is unknown how this condition effects digestion and absorption of enteral nutrition.Normally, the intestine itself metabolizes a substantial part of the nutrients absorbed from the intestinal lumen in first-pass splanchnic uptake (6,7). Animal and human studies have shown that 20 -80% of dietary essential amino acids are used within the intestine (8 -10). The more nutrients are used by the small intestine, the fewer essential amino acids are systemically available for whole-body energy metabolism and protein synthesis. It is unknown whether chemotherapy-induced mucositis affects first-pass splanchnic amino acid uptake. We hypothesized, first, that chemotherapy-induced mucositis will lead to lower nutrient uptake by the intestine and, second, that it will lead to a higher intestinal utilization rate due to mucosal regeneration. The combined result would be a lower systemic availability of dietary amino acids.To test these hypotheses we determined first-pass splanchnic uptake of dietary leucine, an essential amino acid, in pediatric patients before and after receiving mucotoxic chemotherapy.
METHODS
Subjects.The ethics review board of the Erasmus MC-Sophia Children's Hospital approved the study. Informed consent was obtained from parents and patients, as appropriate. Eligible subjects were patients aged between 1 and...